Results 241 to 245 of about 1,995 (245)

EE288 Assessing the Value of Dengue Vaccine TAK 003: A Cost-Effectiveness Study in Malaysia

Value in Health
A Azzeri, H Jaafar, R Ting, J Langer, M Dahlui   +4 more
openaire   +1 more source

Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial

The Lancet Global Health
Vianney Tricou, Shibadas Biswal, Pío López   +2 more
exaly  

Informe sobre vacunas para dengue con foco en TAK-003 (Qdenga) Actualización 2025.

Marín, Gustavo H, Anahí Álvarez-Rotondo, Cañás, Martin, Urtasun, Martin A   +3 more
openaire   +1 more source

TAK-003 Dengue Tetravalent Vaccine: An Integrated Safety Analysis by a Combination of Baseline Dengue Serostatus and Sex

Patel, Sanjay S., Rauscher, Martina, Pang, Hang   +2 more
openaire   +1 more source

AVANÇOS E DESAFIOS NA VACINAÇÃO CONTRA A DENGUE: UMA REVISÃO SOBRE CYD-TDV E TAK-003

Anais do Congresso Zarns Interligas
Vanessa Lara Cardoso, RENNAN MIRANDA TAVARES, Larissa Geovanna Nery Gratao   +2 more
openaire   +1 more source